News

Interstitial lung disease is becoming more prevalent with time. We’re probably diagnosing it more often as we have better imaging modalities that are picking out more subtle interstitial changes ...
Interstitial lung abnormalities (ILAs) are parenchymal lung changes found on high-resolution CT. In routine use of high-resolution CT, non-specific findings are frequently reported, which has prompted ...
Childhood interstitial lung disease (chILD) is a rare disorder that affects babies, children, ... These imaging procedures use X-rays to take pictures of your child’s lungs.
The most common idiopathic interstitial pneumonia is idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fibrotic interstitial lung disease of unknown cause, often with characteristic ...
Phase II PREDICT-ILD Imaging Study Commences in Interstitial Lung Disease. PR Newswire . Tue, Sep 10, 2024, 8:00 AM 5 min read.
Simply having interstitial lung disease by imaging, we’ve seen ranges from 65% to 90% by imaging. For the subsets that are going to progress to have more severe lung disease, that subset is lower.
Trastuzumab Deruxtecan‒Related Interstitial Lung Disease/Pneumonitis: Computed Tomography Imaging Patterns to Guide Diagnosis and Management. JCO Precis Oncol 7 , e2300391 (2023). DOI: ...
A 79-year-old man with recurrent oropharyngeal cancer has developed the first documented case of severe drug-induced interstitial lung disease following photoimmunotherapy with cetuximab-sarotalocan ...
According to data from the Health Insurance Review and Assessment Service in 2023, there are an estimated 15,000 patients ...
Chest CT is the imaging method of choice for analyzing lung disease and tracking changes over time. However, CT studies of lung function and perfusion, or blood flow, require dedicated protocols ...
The pathological differentiation of desquamative interstitial pneumonia has been discussed in some detail. 1 Actually, we believe that this condition could be confused only with other interstitial ...
PURPOSETrastuzumab deruxtecan (T-DXd) is an antibody-drug conjugate approved for the treatment of several advanced cancers; however, severe or fatal interstitial lung disease/pneumonitis can occur. We ...